Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
Nature Reviews. Gastroenterology & Hepatology
|
October 13, 2016
NAFLD and diabetes mellitus
Herbert Tilg, Alexander R Moschen, Michael Roden
European Cytokine Network
|
March 26, 2009
Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?
Herbert Tilg, Alexander R Moschen, Arthur Kaser
Gut and Liver
|
November 22, 2012
Dietary Factors: Major Regulators of the Gut's Microbiota
Alexander R Moschen, Verena Wieser, Herbert Tilg
Hepatology (Baltimore, Md.)
|
January 17, 2016
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg, Alexander R Moschen, Gyongyi Szabo
Clinical Liver Disease
|
May 2, 2019
How does the microbiome affect liver disease?
Herbert Tilg, Christoph Grander, Alexander R Moschen
Nature Reviews. Gastroenterology & Hepatology
|
November 28, 2018
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Alexander R Moschen, Herbert Tilg, Tim Raine
Archivum Immunologiae Et Therapiae Experimentalis
|
January 12, 2013
Inflammation, cytokines and insulin resistance: a clinical perspective
Verena Wieser, Alexander R Moschen, Herbert Tilg
Digestive Diseases (Basel, Switzerland)
|
October 31, 2012
Adipocytokines and hepatocellular carcinoma
Verena Wieser, Alexander R Moschen, Herbert Tilg
Journal of Hepatology
|
July 5, 2011
Pathways of liver injury in alcoholic liver disease
Herbert Tilg, Alexander R Moschen, Nicole C Kaneider
Current Pharmaceutical Design
|
April 8, 2010
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders
Alexander R Moschen, Romana R Gerner, Herbert Tilg
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
Nature Reviews. Gastroenterology & Hepatology
|
October 13, 2016
NAFLD and diabetes mellitus
Herbert Tilg, Alexander R Moschen, Michael Roden
European Cytokine Network
|
March 26, 2009
Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?
Herbert Tilg, Alexander R Moschen, Arthur Kaser
Gut and Liver
|
November 22, 2012
Dietary Factors: Major Regulators of the Gut's Microbiota
Alexander R Moschen, Verena Wieser, Herbert Tilg
Hepatology (Baltimore, Md.)
|
January 17, 2016
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg, Alexander R Moschen, Gyongyi Szabo
Clinical Liver Disease
|
May 2, 2019
How does the microbiome affect liver disease?
Herbert Tilg, Christoph Grander, Alexander R Moschen
Nature Reviews. Gastroenterology & Hepatology
|
November 28, 2018
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Alexander R Moschen, Herbert Tilg, Tim Raine
Archivum Immunologiae Et Therapiae Experimentalis
|
January 12, 2013
Inflammation, cytokines and insulin resistance: a clinical perspective
Verena Wieser, Alexander R Moschen, Herbert Tilg
Digestive Diseases (Basel, Switzerland)
|
October 31, 2012
Adipocytokines and hepatocellular carcinoma
Verena Wieser, Alexander R Moschen, Herbert Tilg
Journal of Hepatology
|
July 5, 2011
Pathways of liver injury in alcoholic liver disease
Herbert Tilg, Alexander R Moschen, Nicole C Kaneider
Current Pharmaceutical Design
|
April 8, 2010
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders
Alexander R Moschen, Romana R Gerner, Herbert Tilg
Page
of 10